Use of spironolactone-based composition that exhibits an inhibitory action on T-lymphocyte activation wich is useful for preventing and/or treating multiple sclerosis exhibits an inhibitory action on T-Lymphocyte activation which is useful for preventing and/or treating multiple
dc.catalogador | jca | |
dc.contributor.author | Kalergis Parra, Alexis Mikes | |
dc.contributor.author | Herrada Hidalgo, Andrés Alonso | |
dc.date.accessioned | 2021-06-14T17:48:19Z | |
dc.date.available | 2021-06-14T17:48:19Z | |
dc.date.concesion | 2017 | |
dc.date.created | 2013 | |
dc.description | Patente de invención | |
dc.estado.patente | CONCEDIDA | |
dc.fechaingreso.objetodigital | No aplica | |
dc.fuente.origen | Propiedad intelectual | |
dc.identifier.UA | Facultad de Ciencias Biológicas | |
dc.identifier.concesion | 9,849,141 | |
dc.identifier.govdoc | 14/104,799 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/60673 | |
dc.language.iso | en | |
dc.nota.acceso | Sin adjunto | |
dc.pais | USA | |
dc.presentacion | Extranjera | |
dc.rights | registro bibliográfico | |
dc.solicitante | Pontificia Universidad Católica de Chile | |
dc.subject | Salud | |
dc.subject.ddc | 610 | |
dc.subject.dewey | Medicina y salud | es_ES |
dc.territorialidad | Extranjera | |
dc.title | Use of spironolactone-based composition that exhibits an inhibitory action on T-lymphocyte activation wich is useful for preventing and/or treating multiple sclerosis exhibits an inhibitory action on T-Lymphocyte activation which is useful for preventing and/or treating multiple | es_ES |
dc.type | patente | |
sipa.codpersvinculados | 90610 | |
sipa.codpersvinculados | 174374 |